Data from NIAGARA supported the FDA’s approval of neoadjuvant durvalumab in combination with gemcitabine and cisplatin, ...
The NIAGARA trial showed that adding durvalumab to neoadjuvant chemotherapy in MIBC patients did not negatively impact HRQOL outcomes. Significant improvement in event-free survival was observed with ...
Pembrolizumab (Keytruda) administered before and after surgery reduced the risk of death by 26% vs placebo in patients with early-stage non–small cell lung cancer (NSCLC), according to 5-year ...
Serplulimab significantly improved event-free survival in gastric cancer, showing potential as a neoadjuvant/adjuvant monotherapy. The combination with chemotherapy achieved a pathologic complete ...
Perioperative care is a critical part of the patient journey. Encompassing the time before, during, and after surgery, perioperative care is a collaborative process that allows clinicians to review a ...
CHICAGO--(BUSINESS WIRE)--Chamberlain University, which has the largest nursing school in the U.S., and the Association of periOperative Registered Nurses (AORN), creators of evidence-based guidelines ...
Comfort nursing combined with targeted operating room care improves recovery, reduces pain, and increases satisfaction in colorectal cancer laparoscopic surgery patients. The dual nursing approach ...
How Should We Manage the Impact of Antimicrobial Resistance in Patients With Cancer? An Oncological and Infectious Disease Specialist Point of View We included 11 RCTs with 2,177 patients in this ...
MedPage Today on MSN
Door Closes on Aggressive Perioperative BP Targets for Select Patients
In the IMPROVE-multi trial of people deemed high-risk for postoperative complications from major abdominal surgery, ...
Efforts to close existing policy gaps and misaligned payment practices in current opioid management practices can promote greater utilization of multimodal opioid-sparing pain management options.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results